Jeffrey Dierks, Chief Commercial Officer at Harmony Biosciences Holdings, Inc. (HRMY), sold 5,000 shares at $35.18 ($176K) on 2021-08-27, disclosed to the SEC on 2021-08-30.
Open-market sale of $176k HRMY by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.01 | 1,600 | $56K | 31.9% |
| 2 | $35.18 | 3,400 | $120K | 68.1% |
| Total | $35.13 avg | 5,000 | $176K | 100% |
| Filing → |
| HRMY | SELL | 2025-01-21 | $2.3M | — | Filing → |
| HRMY | SELL | 2025-01-16 | $778K | — | Filing → |
| HRMY | SELL | 2025-01-15 | $532K | — | Filing → |